dihydroxyphenylalanine has been researched along with 1-(3-chlorophenyl)piperazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esposito, E; Samanin, R; Spampinato, U | 1 |
| Antkiewicz-Michaluk, L; Rokosz-Pelc, A; Vetulani, J | 1 |
2 other study(ies) available for dihydroxyphenylalanine and 1-(3-chlorophenyl)piperazine
| Article | Year |
|---|---|
Serotonin agonists reduce dopamine synthesis in the striatum only when the impulse flow of nigro-striatal neurons is intact.
Topics: 4-Butyrolactone; Animals; Benserazide; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Male; Methoxydimethyltryptamines; Neurons; Piperazines; Rats; Serotonin Antagonists; Substantia Nigra | 1985 |
5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Cyproheptadine; Dihydroxyphenylalanine; Piperazines; Quinolines; Quipazine; Rabbits; Rats; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Time Factors; Tyrosine 3-Monooxygenase | 1980 |